Susan M. Bjorge

Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid

Susan M. Bjorge, Thomas A. Baillie · Biochemical and Biophysical Research Communications · 1985 · 85 citations

Life Sciences, Biochemistry, Pharmacology +15

Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.

Albert W. Rettenmeier, K S Prickett, W. Perry Gordon et al. · Drug Metabolism and Disposition · 1985 · 85 citations

Pharmacy, Pharmacology, Toxicology +17

On-Line Liquid Chromatography-Accurate Radioisotope Counting Coupled with a Radioactivity Detector and Mass Spectrometer for Metabolite Identification in Drug Discovery and Development

A.- E. F. Nassar, Susan M. Bjorge, Do-Kyeong Lee · Analytical Chemistry · 2003 · 65 citations

Natural Sciences, Pharmaceutical Analysis, Pharmacology +17

Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations.

Susan M. Bjorge, Thomas A. Baillie · Drug Metabolism and Disposition · 1991 · 64 citations

Life Sciences, Biochemistry, Cellular Metabolism +16

Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.

Thomas F. Woolf, W F Pool, Susan M. Bjorge et al. · Drug Metabolism and Disposition · 1993 · 62 citations

Medicine, Biochemistry, Pharmacology +17